Effect of L-carnitine in Ischemic Stroke

Phase 3

Recruiting

• Conditions: Ischemic stroke.; Cerebral infarction

• Registration Number: IRCT20221206056734N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Diagnosing and confirming the occurrence of ischemic stroke through clinical and neurological examinations by a neurologist and brain imaging (CT-Scan or MRI)
Be over 18 years old.
Body mass index be more than 18.5.
Having an NIHSS score of greater than 10 and less than 22.
The onset of symptoms be less than 24 hours.
Having focal neurologic deficit
Insensitivity to L-carnitine supplement
No history of previous stroke, craniotomy, and other CNS diseases such as seizures, epilepsy, brain tumor, severe brain injury, multiple sclerosis, Alzheimer's, Parkinson's, etc.
Not taking antioxidant or anti-inflammatory supplements or multivitamins in the last three months
Not suffering from chronic or acute liver and kidney disorders (kidney failure and dialysis)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified